Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Apr 19;66(4):e0212421.
doi: 10.1128/aac.02124-21. Epub 2022 Mar 21.

Different Conformations Revealed by NMR Underlie Resistance to Ceftazidime/Avibactam and Susceptibility to Meropenem and Imipenem among D179Y Variants of KPC β-Lactamase

Affiliations

Different Conformations Revealed by NMR Underlie Resistance to Ceftazidime/Avibactam and Susceptibility to Meropenem and Imipenem among D179Y Variants of KPC β-Lactamase

Magdalena A Taracila et al. Antimicrob Agents Chemother. .

Abstract

β-Lactamase-mediated resistance to ceftazidime-avibactam (CZA) is a serious limitation in the treatment of Gram-negative bacteria harboring Klebsiella pneumoniae carbapenemase (KPC). Herein, the basis of susceptibility to carbapenems and resistance to ceftazidime (CAZ) and CZA of the D179Y variant of KPC-2 and -3 was explored. First, we determined that resistance to CZA in a laboratory strain of Escherichia coli DH10B was not due to increased expression levels of the variant enzymes, as demonstrated by reverse transcription PCR (RT-PCR). Using timed mass spectrometry, the D179Y variant formed prolonged acyl-enzyme complexes with imipenem (IMI) and meropenem (MEM) in KPC-2 and KPC-3, which could be detected up to 24 h, suggesting that IMI and MEM act as covalent β-lactamase inhibitors more than as substrates for D179Y KPC-2 and -3. This prolonged acyl-enzyme complex of IMI and MEM by D179Y variants was not observed with wild-type (WT) KPCs. CAZ was studied and the D179Y variants also formed acyl-enzyme complexes (1 to 2 h). Thermal denaturation and differential scanning fluorimetry showed that the tyrosine substitution at position 179 destabilized the KPC β-lactamases (KPC-2/3 melting temperature [Tm] of 54 to 55°C versus D179Y Tm of 47.5 to 51°C), and the D179Y protein was 3% disordered compared to KPC-2 at 318 K. Heteronuclear 1H/15N-heteronuclear single quantum coherence (HSQC) nuclear magnetic resonance (NMR) spectroscopy also revealed that the D179Y variant, compared to KPC-2, is partially disordered. Based upon these observations, we discuss the impact of disordering of the Ω loop as a consequence of the D179Y substitution. These conformational changes and disorder in the overall structure as a result of D179Y contribute to this unanticipated phenotype.

Keywords: D179Y; KPC; KPC D179Y; Klebsiella pneumoniae; antibiotic resistance; beta-lactamases; ceftazidime-avibactam resistance.

PubMed Disclaimer

Conflict of interest statement

The authors declare a conflict of interest. Dr. Bonomo reports grants from Entasis, Merck, Shionogi, and Venatorx.

Figures

FIG 1
FIG 1
Expression of KPC-2 and KPC-3 did not differ significantly from that of D179N and D179Y variants. RT-PCR data for gene expression by E. coli DH10-β in (A) LB medium and (B) LB medium supplemented with ceftazidime (32 μg/mL) are shown. Expression of KPC-2 and KPC-3 was set at 1.0 (normalized to 16S rRNA), and relative expression of variant genes is presented as the mean ± standard deviations. NS, nonsignificant, P > 0.05. *, KPC3/D179Y expression (0.77 ± 0.09 [P = 0.01]) was not considered significantly decreased since the difference relative to that of KPC3 was ≤2-fold (1.3-fold).
FIG 2
FIG 2
Thermal denaturation by differential scanning fluorimetry shows that KPC-2 D179Y (A) and KPC-3 D179Y (B) exhibit lower melting temperatures (Tm) than the corresponding WT enzyme. An analysis to extract the Gibbs free energy of unfolding (ΔuG) confirms that KPC-2 D179Y (C) and KPC-3 D179Y (D) are thermodynamically less stable than the corresponding WT enzymes. The addition of MEM significantly stabilizes KPC-3 D179Y, as evidenced by increases in Tm and Δu. (E) The fraction of folded protein, determined by a sigmoidal Boltzmann fit to differential scanning fluorimetry data, is provided for WT (KPC-2 WT) and D179Y KPC-2 (KPC-2 D179Y) in the apo form, or in the presence of MEM or CAZ. (F) The fraction of folded protein, determined by a sigmoidal Boltzmann fit to differential scanning fluorimetry data, is provide for WT (KPC-3 WT) and D179Y KPC-3 (KPC-3 D179Y) in the apo form, or in the presence of MEM or CAZ.
FIG 3
FIG 3
NMR spectra at 308 K of WT KPC-2 (A) and D179Y KPC-2 (B) are markedly different. Poorer chemical shift dispersion and broadening of resonances for D179Y KPC-2 (B) compared to those for WT KPC-2 (A) suggest that D179Y KPC-2 is partially disordered at 308 K. Blue squares with labels indicate resonance assignments from WT KPC-2 for a selected subset of residues near the active site or Ω loop (A). The corresponding positions in the D179Y KPC-2 spectra are also shown as blue squares (B).
FIG 4
FIG 4
Superimposition of KPC-2 versus KPC-3, both with the D179Y substitutions, shows that the 2 enzymes have similar overall structures (A). However, the D179Y substitution (yellow) disorders the Ω-loop in KPC-2 and KPC-3 (B). The most significant change is the disruption of the ionic bond between E166 and K73, present in KPC-2 WT but not the variant, and the movement of K73 away from E166 (≈3.7 Å) and toward S70, to an H-bond distance (1.6 Å). R164 is shifting with ∼3 Å, and the ionic bond with D179 present in WT is replaced by steric interactions of Y179 with D163 in the variant (B). The catalytic water is displaced from E166-N170, and with the K73 moving away from E166, toward S70 and S130, the electrostatics of the D179Y active site are significantly changed.
FIG 5
FIG 5
KPC-2 (A) versus D179Y (B) models during 500 ps molecular dynamic simulation (MDS). The substitution at position D179 is changing the shape of the loop leading to major interactions being disrupted (an ionic bond D179-R164), with new interactions between Y179-R164 being created. During the KPC-2 MDS, the K73 residue maintains the ionic bond with E166 and is moving away from S70 (from 2.6 to 4 Å). The K73 in the variant is making H-bonds with N132, and the catalytic water is better positioned between E166-N170-S70 in the D179Y variant versus KPC-2 as well (B).
FIG 6
FIG 6
Molecular models of KPC-2 (A) versus D179Y (B) as acyl-enzymes, with MEM bound. The acyl MEM is perfectly positioned into the active site of KPC-2, ready for deacylation. The catalytic water (WAT) is placed between E166 and N170, makes H-bonds with E166-S70, and is readily available for proton transfer. A second WAT is in the proximity of, and ready to form H-bonds with, N132 and E166.
FIG 7
FIG 7
MDS of CAZ docked into active site of KPC-2 D179Y variant as acyl-enzyme complex, with snap shots at different times: t = 0 ps (A) and t = 200 ps (B). We follow the conformational changes and catalytic water movement during the 500 ps MDS. Deacylation water, present in the active site at the beginning of MDS simulation, does not make H-bonds with S70 (A). The H-bond distance between WAT and K73 is preserved for most of the MDS, and the WAT molecule makes/breaks bonds with S70. This supports the hypothesis that K73 can act as a general base by activating the WAT in the hydrolysis of CAZ.

Similar articles

Cited by

References

    1. Levitt PS, Papp-Wallace KM, Taracila MA, Hujer AM, Winkler ML, Smith KM, Xu Y, Harris ME, Bonomo RA. 2012. Exploring the role of a conserved class A residue in the omega-loop of KPC-2 beta-lactamase: a mechanism for ceftazidime hydrolysis. J Biol Chem 287:31783–31793. 10.1074/jbc.M112.348540. - DOI - PMC - PubMed
    1. Winkler ML, Papp-Wallace KM, Bonomo RA. 2015. Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV beta-lactamases with single amino acid substitutions in the omega-loop. J Antimicrob Chemother 70:2279–2286. 10.1093/jac/dkv094. - DOI - PMC - PubMed
    1. Livermore DM, Warner M, Jamrozy D, Mushtaq S, Nichols WW, Mustafa N, Woodford N. 2015. In vitro selection of ceftazidime-avibactam resistance in Enterobacteriaceae with KPC-3 carbapenemase. Antimicrob Agents Chemother 59:5324–5330. 10.1128/AAC.00678-15. - DOI - PMC - PubMed
    1. Shields RK, Potoski BA, Haidar G, Hao B, Doi Y, Chen L, Press EG, Kreiswirth BN, Clancy CJ, Nguyen MH. 2016. Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant Enterobacteriaceae infections. Clin Infect Dis 63:1615–1618. 10.1093/cid/ciw636. - DOI - PMC - PubMed
    1. Shields RK, Chen L, Cheng S, Chavda KD, Press EG, Snyder A, Pandey R, Doi Y, Kreiswirth BN, Nguyen MH, Clancy CJ. 2017. Emergence of ceftazidime-avibactam resistance due to plasmid-borne blaKPC-3 mutations during treatment of carbapenem-resistant Klebsiella pneumoniae infections. Antimicrob Agents Chemother 61:e02097-16. 10.1128/AAC.02097-16. - DOI - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources